A systematic review to identify and assess the effectiveness of alternatives for people over the age of 65 who are at risk of potentially avoidable hospital admission by Chalder, Melanie et al.
 1Huntley AL, et al. BMJ Open 2017;7:e016236. doi:10.1136/bmjopen-2017-016236
Open Access 
A systematic review to identify and 
assess the effectiveness of alternatives 
for people over the age of 65 who are at 
risk of potentially avoidable 
hospital admission
Alyson L Huntley,1 Melanie Chalder,1,2 Ali R G Shaw,1 William Hollingworth,3 
Chris Metcalfe,1,4 Jonathan Richard Benger,5,6 Sarah Purdy1
To cite: Huntley AL, Chalder M, 
Shaw ARG, et al.  A systematic 
review to identify and 
assess the effectiveness of 
alternatives for people over 
the age of 65 who are at 
risk of potentially avoidable 
hospital admission. BMJ Open 
2017;7:e016236. doi:10.1136/
bmjopen-2017-016236
 ► Prepublication history and 
additional material are available. 
To view these files please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2017- 
016236).
Received 2 February 2017
Revised 31 May 2017
Accepted 31 May 2017
For numbered affiliations see 
end of article.
Correspondence to
Dr Alyson L Huntley;  
 alyson. huntley@ bristol. ac. uk
Research
ABSTRACT
Background/objectives There are some older patients 
who are ‘at the decision margin’ of admission. This 
systematic review sought to explore this issue with the 
following objective: what admission alternatives are 
there for older patients and are they safe, effective and 
cost-effective? A secondary objective was to identify 
the characteristics of those older patients for whom the 
decision to admit to hospital may be unclear.
Design Systematic review of controlled studies (April 
2005–December 2016) with searches in Medline, Embase, 
Cinahl and CENTRAL databases. The protocol is registered 
at PROSPERO (CRD42015020371). Studies were assessed 
using Cochrane risk of bias criteria, and relevant reviews 
were assessed with the AMSTAR tool. The results are 
presented narratively and discussed.
Setting Primary and secondary healthcare interface.
Participants People aged over 65 years at risk of an 
unplanned admission.
Interventions Any community-based intervention offered 
as an alternative to admission to an acute hospital.
Primary and secondary outcomes measures Reduction 
in secondary care use, patient-related outcomes, safety 
and costs.
Results Nineteen studies and seven systematic reviews 
were identified. These recruited patients with both specific 
conditions and mixed chronic and acute conditions. 
The interventions involved paramedic/emergency care 
practitioners (n=3), emergency department-based 
interventions (n=3), community hospitals (n=2) and 
hospital-at-home services (n=11). Data suggest that 
alternatives to admission appear safe with potential to 
reduce secondary care use and length of time receiving 
care. There is a lack of patient-related outcomes and cost 
data. The important features of older patients for whom 
the decision to admit is uncertain are: age over 75 years, 
comorbidities/multi-morbidities, dementia, home situation, 
social support and individual coping abilities.
Conclusions This systematic review describes and 
assesses evidence on alternatives to acute care for older 
patients and shows that many of the options available are 
safe and appear to reduce resource use. However, cost 
analyses and patient preference data are lacking.
InTRoDuCTIon
Reducing emergency bed days is one of 
the biggest challenges currently facing the 
National Health Service (NHS) in the UK, 
and there is considerable pressure to reduce 
hospital admissions among older people 
throughout the developed world.1 It has 
been suggested that clinicians should ‘choose 
to admit only those frail older people who 
have evidence of underlying life-threatening 
illness or need for surgery.’2 In the UK, there 
has been a 65% increase in hospital admis-
sions for those over 75 years of age in the last 
decade. Furthermore, people over 85 years of 
age now account for 11% of emergency admis-
sions and 25% of critical care bed days.3 The 
international literature indicates that deci-
sions to admit to an acute hospital (AH) are 
often influenced by inadequate knowledge 
of the patient or condition, communication 
difficulties between primary and secondary 
care, presence of comorbidities, availability 
of test results, perceived benefits of in-patient 
care and patient preferences.4 A review by 
NHS England highlighted the need to iden-
tify those frail and elderly people who need 
care but do not have a medical need requiring 
Strengths and limitations of this study
 ► High-quality systematic review of controlled studies.
 ► Specific focus on admission avoidance interventions 
for acute care of older people.
 ► Studies cover a wide range of acute conditions and 
acute exacerbation of chronic conditions in older 
people. 
 ► Some of the studies are pragmatic in approach and 
are at high risk of bias.
 ► Most studies do not provide associated costs/cost 
analyses of interventions or patient preference data.
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hospital admission.3 It is clear that there are some older 
patients for whom care in the community is safe, perhaps 
with provision of additional services, and some for whom 
admission is required to deliver diagnostics or treat-
ment that are only available in a hospital. However, for 
those patients ‘at the decision margin,’ the best path of 
action may be unclear.5 The decision may be affected by 
non-clinical and clinical factors (eg, multi-morbidity, how 
much risk the patient or family is willing to accept).
Our specific objective was to conduct a systematic review 
to identify studies of community-based interventions 
aimed at reducing secondary care use in older patients 
with acute medical problems potentially requiring 
unscheduled hospital admission. A secondary objective 
was to further confirm the characteristics of those older 




The protocol for the systematic review was registered at 
the PROSPERO register on 14 June 2015. The registration 
number is CRD42015020371 (supplementary material).
eligibility criteria
Publications of any randomised or non-randomised 
controlled trial (RCT or nRCT) that fitted our PICO 
criteria: a Population aged over 65 years, of either sex 
living in Organisation for Economic Co-operation 
and Development countries being considered for an 
unplanned admission, receiving either an Interven-
tion considered to be an alternative to AH admission or 
AH admission (Control). The studies needed to record at 
least one of the following as either a primary or secondary 
Outcome: intervention effectiveness in terms of patient’s 
subsequent emergency department (ED) attendance or 
readmission, patient-related outcomes, safety or health-
care costs.
Information sources and searches
Medline, Medline In-Process, Embase, Cinahl and 
CENTRAL databases were searched from January 
2005 to April 2015 inclusively using search terms based 
on the eligibility criteria (online supplementary appendix 
1). An update was run in December 2016 across Medline 
and Medline In-Process. We included any relevant system-
atic reviews published 2010–2016. The decision to time 
limit the searches was based on the fact that the system-
atic reviews would cover any older studies and that any 
evidence not included in these two sources was unlikely 
to be relevant to the fast-changing primary and secondary 
healthcare interface. The King’s Fund and Agency for 
Healthcare Research and Quality websites were also 
searched in April 2015.6 7 References were managed 
using EndNote X6 software and were screened by title 
and abstract followed by full text, both independently 
and in duplicate (AH, BD), using predefined inclusion/
exclusion criteria. Any disagreements in either stage were 
resolved using a third reviewer (SP). The reference lists of 
included studies were checked, and forward referencing 
was conducted using Google Scholar. Authors of included 
studies were contacted for details of any extra studies.
Data items and collection process
Data from all primary studies (2005–2016) were extracted 
into a custom-designed table. The main results and 
conclusions of recent high-quality systematic reviews 
(2010–2016) that included relevant primary studies were 
also recorded.
Assessment of risk of bias of individual studies
The Effective Practice and Organisation of Care Cochrane 
risk of bias tool was used to critically appraise RCTs and 
nRCTs (online supplementary appendix 2).8
Assessment of methodological quality of systematic reviews 
(AMSTAR)
The AMSTAR checklist was used to assess the quality of 
the included systematic reviews (online supplementary 
appendix 3).9
Synthesis of results
The data are presented narratively describing, if present, 
the most relevant systematic review and/or individual 
studies for each intervention and, where appropriate, for 
a specific condition.
In order to identify the characteristics of those older 
patients for whom the decision to admit to hospital may 
be unclear, the inclusion/exclusion criteria and demo-
graphics of the participants were examined and key 
features were tabulated alongside the number and refer-
ences of relevant studies.
ReSulTS
The systematic review identified four types of intervention 
from across 19 studies published in 24 papers: paramedic 
practitioners (PPs)/emergency care practitioners (ECPs) 
(n=3), ED interventions (n=3), community hospi-
tals (CHs) (n=2) and hospital-at-home (HaH) services 
(n=11)10–33 (PRISMA diagram) (online supplementary 
file 4). Ten of the included studies were RCTs and nine 
were nRCTs (online supplementary summary table). 
Fifteen studies were conducted in western European 
countries of which four were in the UK. Two studies were 
conducted in Australia and two studies in the USA. Risk 
of bias, general intervention description, AMSTAR and 
study data are detailed in the appendices (online supple-
mentary appendices 1–4, supplementary file 6). There was 
an obvious divide between risk of bias of RCTs and nRCTs 
with the RCTs generally at low risk for most domains, 
although for some domains, there was insufficient infor-
mation to be make a judgement (online supplementary 
appendix 2). The nRCTs were at high risk from not being 
randomised, and in some studies, there was a suggestion 
of health professional choice in allocation and, as with 
the RCTs, information was sometimes lacking. Risk of 
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bias of individual studies is detailed below in the relevant 
section.
The AMSTAR ratings of the systematic reviews were 
generally good, although some reviews did not list 
details of excluded studies, included studies of high 
risk of bias and did not perform publication bias anal-
ysis (online supplementary appendix 3).
PP/eCP interventions
Three studies were identified 10–12 and no relevant recent 
systematic reviews (online supplementary appendix 4).
A cluster RCT compared PPs with additional training 
(n=1469) with standard PPs (n=1549) in assessing and 
treating elderly people following 999 calls with the aim 
of measuring subsequent emergency care.10 Similarly, 
two more recent nRCT investigated the role of ECPs in 
avoiding ED attendance/admissions in elderly popu-
lations.11 12 Gray performed a case-series study of ECP 
attendances for elderly patients aged over 65 years with 
a fall (n=233) compared with historical controls (n=772), 
and Mason et al performed a cluster controlled study 
of enhanced ECP care for five care homes (n=256) 
compared with standard care in five other care homes 
(n=201). Risk of bias was low for all the domains of the 
cluster RCT, and both of the nRCTs were at high risk due 
to lack of randomisation.
In the cluster RCT, all primary outcomes comparing 
the intervention with the control group were improved: 
relative risk of ED attendance within 28 days (RR 0.72 
(0.68, 0.75)), relative risk of hospital admission within 28 
days (RR 0.87 (0.81, 0.94)), being very satisfied with care 
(RR 1.16 (1.09, 1.23)) and mean total episode duration 
in hours (−42.2 (−59.5, −25.0)) with a reported p<0.001 
for all.10 The secondary outcome of mortality was compa-
rable between groups, but intervention patients had a 
greater number of subsequent unplanned contacts with 
secondary care at 28 days (330 vs 259, p<0.01).
The two nRCTs reported a greater reduction in admis-
sions when comparing the intervention with normal ECP 
practice, but these results are of limited use due to the 
high risk of bias of the studies.11 12
None of the studies of PP/ECP interventions provided 
details of cost data or cost-effectiveness analysis.
eD interventions
The searches identified one RCT (Sun et al) that was 
assessed to be at low risk of bias, and two nRCTs (Benaiges 
et al, Salvi et al) in which the risk of bias was high for several 
domains including randomisation.13–15 No relevant, 
recent systematic reviews were identified (online supple-
mentary appendix 4).
Sun and colleagues conducted an RCT in which 
patients attending ED with syncope were randomised to 
receive either a syncope protocol in an observation unit 
(n=62) or usual care (n=62)13 where the maximum stay 
in the observation unit could not exceed than 24 hours.
In terms of primary outcomes, patients randomised to 
the intervention spent less time in hospital at the index 
visit (29 vs 47 hours p<0.001) and were less likely to be 
admitted to hospital (RR 0.16 (95% CI 0.09 to 0.29), 
p<0.001). There were no differences in the secondary 
outcomes of serious events, quality of life (QoL) or satis-
faction with care between groups. A reduction in costs 
was reported, but no formal statistical comparison was 
performed (index visit: US$1400 vs US$2420; 30 days: 
US$1800 vs US$2520 (2011 data)).
The first of the two nRCT compared usual care with 
treatment in a ‘day hospital’ for hyperglycaemic crisis 
from which the main result was improved readmission 
rates and associated costs (Benaiges et al), while the 
second nRCT compared a specialist geriatric ED inter-
vention with a standard ED procedure (Salvi et al) but 
without evidence of any differences in outcome and had 
significant differences in baseline demographic data. 14 15
Ch interventions
Two RCTs were identified describing a CH intervention 
as an alternative to AH care16–19 and no relevant, recent 
systematic reviews (online supplementary appendix 4).
Both RCTs were at low risk of bias overall. In the RCT 
by Vicente et al, participants were randomised following 
triage at home to either go to CH (n=410) or to ED 
(n=396).16 The data presented were limited. The authors 
reported that the nurse attending the patient at home sent 
90 intervention participants to CH (primary outcome), 
although 6 of those individuals were subsequently trans-
ferred from CH to ED (secondary outcome). There were 
no formal statistical analyses, and cost data were not 
presented.
The Garåsen RCT compared CH care (n=72) with AH 
care (n=72) and was published over three separate 
papers. 17–19 There was no distinction between primary 
and secondary outcomes. At 26 weeks, there were fewer 
readmissions in the CH group versus the AH group (19% 
vs 36%, p=0.02) and more people receiving no care (25% 
vs 10%, p=0.01). At 12 months, there were fewer deaths in 
the CH group (18% vs 31%, p=0.03), although the obser-
vation period was considerably longer in the CH group 
(335.7 vs 292.8 days, p=0.01). Total cost of treatment 
was less in the CH group compared with those receiving 
AH care: NOK 39 650 ((95% CI NOK 30 996 to 48 304) 
vs NOK 73 417 (95% CI NOK 52 992 to 93 843)), data 
collected in 2003–2005 (p=0.002). Average health services 
costs per patient/day for the entire observation period 
was NOK 606 (95% CI NOK 450 to 761) in the CH group 
compared with NOK 802 (95% CI NOK 641 to 962) in the 
AH group (p=0.026).
hah interventions
Eight of the HaH studies were focused on specific condi-
tions: heart failure (HF) (n=3), chronic obstructive 
pulmonary disease (COPD) (n=1), pulmonary embolism 
(n=1), pneumonia (n=1), stroke (n=1) and uncom-
plicated diverticulitis (n=1).20–28 The remaining three 
HaH studies recruited older participants with a range 
of conditions, and two of these recruited from residen-
tial homes.29–33 All the specific condition studies were 
included in recent (2010–2016) systematic reviews,34–40 
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but no relevant reviews for the older participants with a 
range of conditions were identified (online supplemen-
tary appendix 4).
Heart failure
Three RCTs were identified on HaH for HF, and their 
results were published in four separate papers.20–23 These 
studies were included in two previous reviews of HaH, 
one of which focused on HF (Quaddoura et al).34 35 This 
review used the Cochrane risk of bias tool and described 
the overall quality of the RCTs as modest. The AMSTAR 
rating of the review highlighted a lack of description of 
excluded studies and the combination of different QoL 
measures in meta-analysis.
In the Quaddoura systematic review, the patients 
were randomised to either HaH or AH within the ED 
and the primary outcomes of the review were hospital 
readmissions and mortality. HaH increased time to 
first readmission (mean difference 14.13 days (95% 
CI 10.36 to 17.91), p=0.015) using data from two RCTs 
(n=132),22 23 although there was no strong evidence of an 
effect on the rate of readmission (RR 0.68 (0.42, 1.09)) 
using data from two RCTs (n=172).20 22 This is a sizeable 
reduction but consistent with chance in a data set of this 
size. An improvement was reported in health-related 
QoL at both 6 and 12 months (standardised mean differ-
ence (SMD) −0.31 (−0.45 to −0.18); SMD −0.17 (−0.31 to 
−0.02), respectively). HaH was comparable to AH care 
on all-cause mortality (RR 0.94 (0.67, 1.32)) using data 
from all three RCTs. These studies also showed a signif-
icant reduction in costs for the index treatment period 
(p<0.001). Two trials20 23 reported lower costs in the HaH 
group at 12 months, although the difference was not 
statistically significant in one of the studies.20 When the 
authors of this particular review calculated total costs for 
these two trials, both indicated a cost reduction for HaH 
compared with AH care.
Chronic obstructive pulmonary disease
An RCT by Ricauda was published in 2008 and was also 
included in two recent systematic reviews, one focusing 
on COPD and one more generally on HaH.24 35 36 The 
high-quality COPD review included eight RCTs, one of 
which described HaH in an early discharge setting, plus 
the Ricauda trial and six that were published prior to our 
2005 inclusion date.
The Ricauda RCT compared HaH (n=52) with AH 
(n=52) and was conducted with low risk of bias. The 
primary outcomes were hospital readmission and 
mortality rates at 6 months. The secondary outcomes 
included a range of depression, functional, cognitive and 
nutritional measures as well as costs.
The study showed that there were fewer hospital read-
missions for HaH patients compared with AH patients at 
6 months (42% vs 87%, p=0.001), although HaH patients 
had a longer length of stay than those in the AH group 
(15.5 SD±9.5 vs 11.0±SD 7.9 days, p=0.01). While HaH 
patients experienced improvements in depression and 
QoL scores during the study, there was no evidence of 
difference between the two groups for these outcomes at 
6 months. Cumulative mortality at 6 months was compa-
rable between groups (20.2%).
All patients discharged from HaH completed the care 
programme at home, whereas 11.5% of AH patients 
continued their care in a long-term facility after hospital 
discharge, with an average daily cost of US$174.7 for a 
mean period of 25 ±8.7 days. Overall, on a cost per patient 
per day basis, HaH care was less expensive than that given 
to the AH group (US$101.4±61.3 vs US$151.7±96.4, 
p=0.002). This RCT reflected the results of the published 
systematic review.36
Pulmonary embolism
Our review identified one published nRCT of HaH (Rodri-
guez-Cerillo et al) for patients with pulmonary embolism, 
which was also included in a recent systematic review with 
seven other observational studies (Vinson et al).25 37 The 
high-quality review concluded that the overall incidence 
of mortality at 90 days was very low.
The nRCT compared HaH (n=30) with AH (n=31) and 
was at high risk of bias overall.25 No distinctions between 
primary and secondary outcomes were made. Mean 
length of stay was not statistically different comparing 
HaH with the AH group (8.9 days (7–14 days) vs 10.6 days 
(6–20 days)). No patients treated at home required unex-
pected return to hospital during admission. There was no 
major bleeding, thrombosis or death in either group at 
90 days in the nRCT.25 There were no cost data reported.
Pneumonia
Our review identified one RCT (Carratala et al) published 
and included in a recent systematic review (Chalmers 
et al) that also described a further five studies comprising 
a variety of designs.26 38 The RCT compared HAH (n=110) 
with AH (n=114) and was at low risk of bias. The primary 
outcome was the percentage of patients with an ‘overall 
successful outcome’ according to seven predefined 
criteria,26 while secondary outcomes were patients’ QoL 
and satisfaction.
An overall successful outcome was achieved in 83.6% of 
HaH patients and 80.7% of AH patients (absolute differ-
ence 2.9% (95% CI 7.1 to 12.9)). Subsequent hospital 
admissions were comparable between groups (6.3% vs 
7.0%). More HaH patients were satisfied with their overall 
care (91.2% vs 79.1%; ab 12.1% (CI 1.8% to 22.5%)). 
Reported QoL scores were comparable between groups 
as was the percentage of patients with adverse drug reac-
tions (9.1% vs 9.6%), medical complications (0.9% vs 
2.6%) and overall mortality (0.9% vs 0%) for HAH and 
AH patient groups, respectively. There were no cost data 
presented. This RCT data reflect the result of the system-
atic review by Chalmers et al.38
Stroke
One RCT on HaH for stroke patients (Kalra et al) was 
published and also included in two previous system-
atic reviews.27 35 39 This RCT was at low risk of bias. The 
primary outcome measure was death or institutionalisa-
tion at 1 year. This three-arm study randomised patients 
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into care on a stroke unit (SU) (n=152), care in a general 
ward (GW) with stroke expert advice (n=152) and HaH 
with stroke expert advice (n=153) within 72 hours after 
recruitment in the ED department.
Mortality and institutionalisation at 1 year were lower in 
the SU group compared with either the GW (14% vs. 30%, 
p<0.001) or HaH groups (14% vs 24%, p=0.03). Signifi-
cantly fewer patients cared for on the SU died compared 
with those in the GW group (9% vs 23%, p=0.001). The 
SU group showed greater improvement on basic activi-
ties of daily living compared with the other two groups 
(change in Barthel Index: 10 vs 7, p<0.002). QoL at three 
months was significantly better in SU and HaH patients. 
There was greater dissatisfaction with care in the GW 
group compared with SU or HaH groups. The total costs 
of stroke care per patient over 12 months (data collected 
in 2005–2008) were £11 450 for the SU group, £9527 for 
the GW group and £6840 for the HaH group.
Uncomplicated diverticulitis
Our systematic review found one nRCT (Rodriguez-Cer-
rillo et al).28 This study was also included in a recent, 
moderate-quality integrative review on admission-avoid-
ance HaH services.40 This nRCT compared HaH (n=34) 
with AH (n=18) for patients with uncomplicated divertic-
ulitis and was, overall, at high risk of bias with no defined 
primary or secondary outcomes. No statistical detail was 
provided about any of the data presented. None of the 
patients treated at home were transferred to AH. The 
mean length of stay in the intervention group was 9 days, 
compared with 10 days in AH. HaH treatment was associ-
ated with a cost reduction of €1368 per patient.
Older population with acute medical problems
There were three studies identified published over five 
papers29–33 and no relevant recent systematic reviews. 
One nRCT recruited acutely ill older persons and was 
published across three separate papers (Leff et al, main 
publication).29–31 This nRCT compared HaH (n=169) with 
AH (n=286) with the majority of patients being identified 
the morning after admission. The study was at high risk 
of bias.29 There was no distinction made between primary 
and secondary outcomes. Patients treated with HaH had 
a shorter length of stay compared with those given AH 
care (3.2 vs 4.9 days, p=0.004). The mean treatment cost 
was lower for HaH care than for AH care (US$5081 vs 
US$7480, p<0.001). Eight weeks after admission, there 
were no differences in the use of health services between 
HaH and AH patients in terms of ED visits (0.23 (SD 
0.66), 0.22 (SD 0.57)) or readmission (0.28 (SD 0.59), 
0.27 (SD 0.55)).
The nRCT by Crilly et al recruited elderly nursing home 
patients presenting at ED but who were willing to receive 
care back in their nursing home (n=62) and compared 
these with historical control care home patients who had 
been hospitalised (n=115). The study was at high risk of 
bias,32 and no primary outcomes were specified. Interven-
tion participants experienced a longer time in ED than 
those who had been admitted into hospital (9.94 vs 7.01 
hours, p=0.005) but required less time being subsequently 
cared for (2.19 vs 6.2 days, p<0.001). Overall, the length 
of an episode of care in days (9.56 (1.26) vs. 6.20 (0.59) 
days, p=0.14) and the number of readmissions within 28 
days (11.3 vs 11.3, p=0.99) were not statistically different 
between the two groups. There were no mortality or cost 
data presented.
The nRCT by Lau et al assessed residents of a care home 
presenting at ED who were subsequently treated back in 
their care home (n=95) and compared data with histor-
ical hospital controls (ie, not from care homes) (n=167).33 
No primary outcomes were specified, and the study was at 
high risk of bias. Length of stay was significantly shorter 
for those in the intervention group compared with the 
controls (2 vs 11 days, p<0.001), although mortality (11 
(11.6%) vs 20 (12.0%), p=0.924) and readmission rates 
(39 (41.1%) vs 68 (40.7%), p=0.963) at 6 months were 
comparable between groups. There were no cost data 
presented.
Characteristics of those older patients for whom the decision 
to admit to hospital may be unclear
Fifteen of the studies included in our systematic review 
recruited a population with a mean age of more than 
75 years, despite the inclusion criterion specifying those 
over 65 years. While 9 out of 19 studies specifically stated 
that their recruited population was multi-morbid, it is 
plausible that all the study populations were and so this is 
very likely to be a factor that impacts on decision making 
in acute medical care. Eight studies specified a particular 
degree of severity for dementia as an inclusion criterion, 
but in practice, this is a difficult assessment to make in 
the acute care context. There were inclusion/exclusion 
criteria in nine of the studies that specified the impor-
tance of taking account of an individual’s home situation, 
social support networks and coping abilities as part of the 
decision-making process (online supplementary file 7).
DISCuSSIon
Summary of principal findings
The findings of our systematic review show that alterna-
tives to AH care at the point of potential admission for 
people aged over 65 years can be safe, with comparable 
mortality and clinical outcomes across a range of acute 
and chronic conditions. They also have the potential 
to reduce healthcare spending. The exception to the 
evidence of benefit of HaH is the treatment of patients 
with stroke, who fare much worse with HaH intervention 
compared with treatment in an SU. The authors of this 
study suggest that these differences are due to the overall 
expertise available in SU as opposed to care given by 
generic hospital or homecare staff advised by specialised 
stroke health professionals. It is recommended therefore 
that, in most cases, in line with current NHS practice for 
stroke, care should to be provided in specialist units.41 
The key features of older patients for whom the decision 
to admit may be uncertain are age more than 75 years, 
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comorbidities/multi-morbidities, dementia, home situa-
tion, social support and individual coping abilities.
Comparison with previous literature
As part of our systematic review, any relevant systematic 
review published in 2010–2016 was included and referred 
to when discussing the more recent studies. All of these 
reviews were on the topic of HaH interventions. In addi-
tion to being older evidence, some of the previous reviews 
in contrast to our own included a number of uncontrolled 
observational studies. Some also included studies in which 
HaH interventions were applied in the non-emergency or 
postdischarge settings. By contrast, our systematic review 
focuses on bringing together controlled studies on alter-
natives to acute hospitalisation at the point of potential 
admission for those over 65 years old.
Clinical and research implications
For health professionals, making a decision to admit an 
older patient can prove very difficult. Decision making 
for each individual patient draws upon a range of profes-
sional experience and expertise and should also be 
influenced by broader factors such as living conditions 
and individual/family/carer coping, in addition to care 
preferences. If alternatives to acute admission are avail-
able, health professionals must be confident about using 
these alternative pathways for their patients,5 and while 
many of the interventions in this review may provide 
viable alternatives to acute care, they may not exist in 
some healthcare communities or geographical regions. 
Nevertheless, our review suggests that, where established 
alternatives to admission exist, clinicians should offer 
these with a degree of confidence and not assume that 
hospital admission is always the best or safest option for 
their patient.
Future research should aim to provide more compre-
hensive evidence of both the clinical and cost-effectiveness 
of a wider range of hospital alternatives for a greater range 
of health issues, as well as exploring in more detail the 
determinants and outcomes of decision making under 
conditions of uncertainty. Many of the studies included 
in this review recruited highly defined populations, and it 
would be helpful to understand whether the findings can 
be replicated in more general patient groups. There is 
also much to be done to improve the collection of data on 
patient-related outcomes, carer and health professional 
acceptability and costs.
Strengths and limitations of review
Our systematic review was conducted to high meth-
odological standards.42 The majority of evidence 
presented is based on HaH services, although this 
includes treatment of a wide range of conditions. 
While not all the included studies were randomised 
or considered to be at low risk of bias, these issues 
are clearly highlighted and the included studies cover 
a variety of alternative approaches to hospital admis-
sion. The majority of the included studies offer little 
or no cost data, which makes it difficult to assess the 
cost-effectiveness of any these alternatives to AH care. 
While writing our protocol, we planned to carry out a 
meta-analysis on suitable data. However, the data we 
identified were insufficient, in terms of quantity (ie, 
often drawn from a single study), quality (ie, from 
nRCT) or homogeneity. Where sufficient data were 
identified—on HaH for HF—an analysis had already 
been conducted within a previous review.34
In conclusion, this systematic review describes and 
assesses evidence on alternatives to acute care for older 
patients and shows that many of the options available are 
safe and appear to reduce resource use.
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